IT1275434B - Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante - Google Patents

Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante

Info

Publication number
IT1275434B
IT1275434B ITMI951021A ITMI951021A IT1275434B IT 1275434 B IT1275434 B IT 1275434B IT MI951021 A ITMI951021 A IT MI951021A IT MI951021 A ITMI951021 A IT MI951021A IT 1275434 B IT1275434 B IT 1275434B
Authority
IT
Italy
Prior art keywords
pharmaceutical
pct
antioxidant activity
dietary compositions
sec
Prior art date
Application number
ITMI951021A
Other languages
English (en)
Italian (it)
Inventor
Roberto Bianchi
Original Assignee
Farmila Farma Milano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmila Farma Milano filed Critical Farmila Farma Milano
Publication of ITMI951021A0 publication Critical patent/ITMI951021A0/it
Priority to ITMI951021A priority Critical patent/IT1275434B/it
Priority to PCT/EP1996/002079 priority patent/WO1996036348A1/en
Priority to ES96916082T priority patent/ES2159737T3/es
Priority to PT96916082T priority patent/PT825871E/pt
Priority to CA002221455A priority patent/CA2221455C/en
Priority to AU58974/96A priority patent/AU697990B2/en
Priority to EP96916082A priority patent/EP0825871B1/en
Priority to AT96916082T priority patent/ATE204479T1/de
Priority to JP53455596A priority patent/JP4850986B2/ja
Priority to DE69614681T priority patent/DE69614681T2/de
Priority to US08/952,437 priority patent/US5866537A/en
Publication of ITMI951021A1 publication Critical patent/ITMI951021A1/it
Application granted granted Critical
Publication of IT1275434B publication Critical patent/IT1275434B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
ITMI951021A 1995-05-19 1995-05-19 Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante IT1275434B (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
ITMI951021A IT1275434B (it) 1995-05-19 1995-05-19 Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
EP96916082A EP0825871B1 (en) 1995-05-19 1996-05-15 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids
ES96916082T ES2159737T3 (es) 1995-05-19 1996-05-15 Composiciones farmaceuticas y/o dieteticas con actividad antioxidante que contienen carnosina o derivados y aminoacidos ramificados.
PT96916082T PT825871E (pt) 1995-05-19 1996-05-15 Composicoes farmaceuticas e/ou dieteticas com actividade anti-oxidante contendo carnosina ou derivados e amino acidos ramificados
CA002221455A CA2221455C (en) 1995-05-19 1996-05-15 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids
AU58974/96A AU697990B2 (en) 1995-05-19 1996-05-15 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids
PCT/EP1996/002079 WO1996036348A1 (en) 1995-05-19 1996-05-15 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids
AT96916082T ATE204479T1 (de) 1995-05-19 1996-05-15 Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten
JP53455596A JP4850986B2 (ja) 1995-05-19 1996-05-15 カルノシンあるいはその誘導体および分枝アミノ酸を含む抗酸化活性を有する医薬組成物および／または栄養組成物
DE69614681T DE69614681T2 (de) 1995-05-19 1996-05-15 Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten
US08/952,437 US5866537A (en) 1995-05-19 1996-05-15 Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI951021A IT1275434B (it) 1995-05-19 1995-05-19 Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante

Publications (3)

Publication Number Publication Date
ITMI951021A0 ITMI951021A0 (it) 1995-05-19
ITMI951021A1 ITMI951021A1 (it) 1996-11-19
IT1275434B true IT1275434B (it) 1997-08-07

Family

ID=11371632

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI951021A IT1275434B (it) 1995-05-19 1995-05-19 Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante

Country Status (11)

Country Link
US (1) US5866537A (enExample)
EP (1) EP0825871B1 (enExample)
JP (1) JP4850986B2 (enExample)
AT (1) ATE204479T1 (enExample)
AU (1) AU697990B2 (enExample)
CA (1) CA2221455C (enExample)
DE (1) DE69614681T2 (enExample)
ES (1) ES2159737T3 (enExample)
IT (1) IT1275434B (enExample)
PT (1) PT825871E (enExample)
WO (1) WO1996036348A1 (enExample)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2327404A1 (en) * 1994-11-08 2011-06-01 Avicena Group, Inc. Use of creatine or creatine analogs for the treatment of diseases of the nervous system
IT1283967B1 (it) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
US6524611B2 (en) 1996-05-31 2003-02-25 The Howard Foundation Compositions containing creatine and creatinine
US6168802B1 (en) 1996-05-31 2001-01-02 The Howard Foundation Compositions containing creatine and aloe vera extract
US7150880B2 (en) 1996-05-31 2006-12-19 The Original Creatine Patent Co. Ltd. Compositions containing creatine and creatinine and a methyl xanthine
US8128955B2 (en) 1996-05-31 2012-03-06 The Original Creatine Patent Company Food compositions containing creatine
GB9611356D0 (en) * 1996-05-31 1996-08-07 Howard Alan N Improvements in or relating to compositions containing Creatine, and other ergogenic compounds
US6274161B1 (en) 1996-05-31 2001-08-14 The Howard Foundation Compositions containing creatine in suspension
DE19649891C2 (de) * 1996-12-02 1998-12-10 Mk Produktkontor Gmbh Verwendung von antioxidativen Zusammensetzungen mit Süßmolkekonzentrat
CA2280093A1 (en) * 1997-02-04 1998-08-06 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
RU2141483C1 (ru) * 1997-07-04 1999-11-20 Небольсин Владимир Евгеньевич Производные пептидов или их фармацевтически приемлемые соли, способ их получения, применение и фармацевтическая композиция
DE19806890A1 (de) * 1998-02-19 1999-08-26 Beiersdorf Ag Kosmetische und dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Antioxidans sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
AU759467B2 (en) * 1998-04-02 2003-04-17 Avicena Group, Inc. Compositions containing a combination of a creatine compound and a second agent
US20060128671A1 (en) * 1998-04-02 2006-06-15 The General Hospital Corporation Compositions containing a combination of a creatine compound and a second agent
IT1299191B1 (it) * 1998-06-23 2000-02-29 Sigma Tau Healthscience Spa Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
US6149924A (en) * 1998-07-20 2000-11-21 Biomed Research & Technologies, Inc. Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin
EP1100589B1 (en) 1998-07-30 2005-01-19 Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Use of propionyl l-carnitine and acetyl l-carnitine in the preparation of medicaments with anticancer activity
CA2339473A1 (en) * 1998-08-04 2000-02-17 John V. Kosbab Nutrient and therapeutic compositions for the treatment of cancer
IT1302863B1 (it) * 1998-11-13 2000-10-10 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante e preventiva di alterazionitrombotiche e aterosclerotiche comprendente una carnitina ed un
NO993678L (no) * 1999-07-28 2001-01-29 Norsk Hydro As Fôr for salmonider
US6294579B1 (en) 1999-10-11 2001-09-25 Joseph W. Carnazzo Method for improving delivery of tyrosine supplementation
AUPQ515000A0 (en) * 2000-01-19 2000-02-10 Grigg, Geoffrey Walter Treatment of uv induced immunosuppression
US8753675B1 (en) * 2000-01-20 2014-06-17 Raj K. Chopra Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
US6476010B2 (en) 2000-03-10 2002-11-05 Hill's Pet Nutrition Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
US8252309B2 (en) * 2000-04-04 2012-08-28 Sigma-Tau Industrie Farmaceutiche Riunite Spa Dietary supplement energy-providing to skeletal muscles
IT1317008B1 (it) * 2000-04-04 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare energizzante sulla muscolatura scheletrica eprotettivo sull'apparato cardiovascolare.
US20030212136A1 (en) * 2001-09-14 2003-11-13 Vennerstrom Jonathan L. Creatine ester pronutrient compounds and formulations
EP1324760B1 (en) * 2000-09-14 2007-06-20 Board of Regents of the University of Nebraska Creatine ester pronutrient compounds and formulations
DE60212015T2 (de) * 2001-03-16 2006-11-02 Suntory Ltd. Autonomsystem kontrollagentien und gesundheitsgetränke und -nahrungsmittel
AU2003238872A1 (en) * 2002-06-04 2003-12-19 Avicena Group, Inc. Methods of treating cognitive dysfunction by modulating brain energy metabolism
TR200301291A2 (tr) * 2002-08-20 2004-02-23 Dart Industries Inc. Şekil verilmiş gıda maddelerinin oluşturulması için ayarlanabilir kalıp
JP2006504701A (ja) * 2002-09-30 2006-02-09 マーク・エー・バビザイェフ 眼疾患の局所的治療方法、並びに、その治療用組成物及び治療用手段
WO2004064866A1 (ja) * 2003-01-20 2004-08-05 Innovative Vision Products, Inc. カルノシナーゼ阻害剤とｌ−カルノシン類との併用および組成物
RU2255758C2 (ru) * 2003-09-18 2005-07-10 Закрытое акционерное общество "Научно-производственное объединение "ТЕХКОН" Биологически активный карнозин-анзеринсодержащий комплекс и способ его получения
SI1591105T1 (sl) 2004-03-17 2020-09-30 Stada Arzneimittel Ag Uporaba antioksidantov za pripravo farmacevtskega ali kozmetičnega sestavka za zaščito kože pred poškodbo z infrardečim sevanjem
EP1761272B1 (en) 2004-06-08 2013-04-24 Flamma S.P.A. Compositions containing d-carnosine
JP2006052186A (ja) * 2004-08-16 2006-02-23 Toagosei Co Ltd 新規ジヒドロフェルラ酸縮合物
WO2006026304A1 (en) * 2004-08-25 2006-03-09 Ivax Corporation Cardioprotective formulations and uses thereof
JP5336180B2 (ja) 2005-05-23 2013-11-06 ナチュラル オータナティブス インターナショナル β−アラニンの徐放のための組成物及び方法
AU2007249847A1 (en) * 2006-05-11 2007-11-22 Avicena Group, Inc. Methods of treating a neurological disorder with creatine monohydrate
RU2318512C1 (ru) * 2006-09-01 2008-03-10 ГУ Научно-исследовательский институт психического здоровья Томского научного центра Сибирского отделения Российской академии медицинских наук ГУ НИИ психического здоровья ТНЦ СО РАМН Способ реабилитации больных алкоголизмом на этапе формирования ремиссии
US9421262B2 (en) * 2009-10-28 2016-08-23 Biomed Research & Technologies, Inc. Compositions and methods for treating dermatological conditions
WO2011078204A1 (ja) * 2009-12-24 2011-06-30 浜理薬品工業株式会社 高脂血症の予防または治療剤、および抗疲労剤
BR112013016021A2 (en) * 2010-12-21 2018-12-11 Nestec S.A. Appropriate methods and compositions for managing blood glucose in animals
US9233099B2 (en) 2012-01-11 2016-01-12 University Of Cincinnati Methods of treating cognitive dysfunction by modulating brain energy metabolism
JP2014114244A (ja) * 2012-12-11 2014-06-26 Ito En Ltd 抗疲労剤組成物
JP6401028B2 (ja) * 2014-11-27 2018-10-03 Ｓｈｉｏｄａライフサイエンス株式会社 鯨筋肉抽出物からなる中長期記憶障害予防改善剤
JP2016130229A (ja) * 2015-01-15 2016-07-21 有限会社アント アミノ酸溶解物の製造方法および該製造方法により製造したアミノ酸溶解物
FR3056381B1 (fr) * 2016-09-26 2019-11-15 Futur Optimal Composition comprenant de la carnosine
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
BR112020002419A2 (pt) 2017-08-14 2020-07-28 Axcella Health Inc. aminoácido para o tratamento de doença do fígado
CN112839643A (zh) 2018-06-20 2021-05-25 胺细拉健康公司 用于治疗肌肉中脂肪浸润的组合物及方法
US20220218640A1 (en) 2021-01-14 2022-07-14 Rob Dickerman Amino acid delivery system
JP2023156812A (ja) * 2022-04-13 2023-10-25 サントリーホールディングス株式会社 組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1240336B (it) * 1990-03-21 1993-12-07 Setra Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica

Also Published As

Publication number Publication date
DE69614681T2 (de) 2002-07-04
ITMI951021A1 (it) 1996-11-19
JP4850986B2 (ja) 2012-01-11
EP0825871B1 (en) 2001-08-22
ATE204479T1 (de) 2001-09-15
WO1996036348A1 (en) 1996-11-21
JPH11505540A (ja) 1999-05-21
AU5897496A (en) 1996-11-29
EP0825871A1 (en) 1998-03-04
AU697990B2 (en) 1998-10-22
US5866537A (en) 1999-02-02
CA2221455C (en) 2008-07-08
ITMI951021A0 (it) 1995-05-19
CA2221455A1 (en) 1996-11-21
DE69614681D1 (de) 2001-09-27
PT825871E (pt) 2001-12-28
ES2159737T3 (es) 2001-10-16

Similar Documents

Publication Publication Date Title
IT1275434B (it) Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
FR2688422B1 (enExample)
EP1166767A3 (en) Skin care product containing hydroxyproline or N-acylated hydroxyproline derivatives
CA2341973A1 (en) Antioxidant composition comprising acetyl l-carnitine and .alpha.-lipoic acid
IL124674A0 (en) Piperazine derivatives pharmaceutical compositions containing the same and use thereof
GB2288732B (en) Pharmaceutical compositions
IT1312377B1 (it) Composizioni a base di acido tiottico, cisteina e/o n-acetil cisteinada utilizzarsi in preparazioni farmaceutiche, dietetiche e cosmetiche
BR9609413A (pt) Formulações de dieta e farmacêuticas para a profilaxia e o tratamento de distúrbios gastrintestinais
GEP20063818B (en) Orodispersible pharmaceutical composition comprising agomelatine
ES2191174T3 (es) (-)hidroxicitrato de magnesio, procedimiento de preparacion, aplicaciones y composiciones principalmente farmaceuticas que lo contienen.
ATE271392T1 (de) Lipoproteinkomplexe und zusammensetzungen, die diese enthalten
HUP9900085A3 (en) Azine derivatives, of amino acids and pharmaceutical compositions containing them
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
AU7575394A (en) Substituted 1-naphthyl-3-pyrazolecarboxamides which are active on neurotensin, their preparation and pharmaceutical compositions containing them
GB9424766D0 (en) Pharmaceutical composition
CA2215470A1 (fr) Composes biaryles heterocycliques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
NZ333966A (en) Use of 1-nonen-3-one as a flavouring agent
BR9809368A (pt) Composições sólidas adequadas para administração oral compreendendo l-carnitina ou fumarato de magnésio de alcanoil-l-carnitina.
GB2379855A (en) Dietary regime for companion animals
BR0211245A (pt) Alimento contendo proteìna compreendendo uma enzima de ligação cruzada e um hidrocolóide
GEP20063820B (en) Orodispersible pharmaceutical composition comprising ivabradine
BR0213536A (pt) Formulações de xarope de ribavirina
GEP20063821B (en) Orodispersible pharmaceutical composition comprising perindopril
CA2217513A1 (en) Pharmaceutical agents for the treatment of alzheimer's disease
DK1409449T3 (da) Alpha-ketoglutarater af aktive ingredienser og sammensætninger omfattende disse

Legal Events

Date Code Title Description
0001 Granted